<!DOCTYPE html>
<html>
<head>
    <meta charset="utf-8">
    <link rel="stylesheet" href="https://cdn.jsdelivr.net/npm/@picocss/pico@2/css/pico.classless.min.css">
    <title>Report 10-Nov-2025</title>
</head>
<body>
<main>
<a href="https://github.com/pathikrit/zeitgeist" target="_blank" rel="noopener" style="float: right;">
    <img src="https://github.githubassets.com/images/modules/logos_page/GitHub-Mark.png" alt="GitHub" width="30" height="30">
</a>
<h1>Daily Memo (10-Nov-2025)</h1>
<hr />
<h2>Key News &amp; Market-Moving Headlines</h2>
<ul>
<li>
<p><strong>US Senate Breaks Shutdown, Stimulus Talks Ongoing:</strong></p>
<ul>
<li>Senate advances key vote to reopen government after protracted shutdown. Market rallies on expectation of resolution.</li>
<li>Trump administration floats using tariff revenue to send $2,000 “dividend” checks to most Americans, with economists warning of longer-term inflation/stagflation and consumption risks.</li>
<li>FAA restricts private jets at major airports due to staffing issues from shutdown; major disruptions in air travel ongoing.</li>
</ul>
</li>
<li>
<p><strong>Weather / Natural Disaster:</strong></p>
<ul>
<li>Super typhoon Fung-wong causes mass displacement in the Philippines, heads toward Taiwan—heightening supply chain risk and questions for insurers, agriculture, and global shipping.</li>
<li>Intensifying Arctic Blast: US Midwest and East Coast face severe winter weather, impacting energy demand and potentially retail logistics.</li>
</ul>
</li>
<li>
<p><strong>Global Geopolitics:</strong></p>
<ul>
<li>Further divisions in Europe as investigations into Nord Stream pipeline explosions implicate Ukrainian actors; could complicate EU support and energy policy.</li>
<li>Israel receives remains of soldier from Hamas amid ongoing Gaza conflict. Continued fighting and talk of further ground offensives keep Middle East risk premium high.</li>
<li>Saudi Arabia/Israel normalization remains unresolved but in focus.</li>
</ul>
</li>
<li>
<p><strong>Healthcare &amp; Science:</strong></p>
<ul>
<li>New CRISPR-based cholesterol drug halves LDL in early trials—signaling further momentum for next-gen therapeutics.</li>
<li>US appeals court keeps full SNAP benefits flowing, but legal immigrants may lose Obamacare support—implications for insurers and healthcare sectors.</li>
</ul>
</li>
<li>
<p><strong>Corporate / Tech:</strong></p>
<ul>
<li>Apple reportedly developing ambitious satellite iPhone features, stoking innovation expectations.</li>
<li>Samsung Galaxy S26 and Exynos chip news signals competitive pressure on Apple.</li>
<li>Market strategists turning more cautious after broad “buy everything” rally stalls.</li>
</ul>
</li>
</ul>
<hr />
<h2>Macro Overview</h2>
<h3>US Macroeconomy</h3>
<ul>
<li>
<p><strong>Government Funding &amp; Fiscal:</strong></p>
<ul>
<li>Government shutdown is on track to end, removing a near-term macro risk but highlighting fiscal gridlock. Most federal employees set to get back pay.</li>
<li>Fiscal deficit and debt trajectory remains problematic: National debt will likely breach $38T by year-end, with additional increases projected through 2027—fueling future pressure on Treasuries, TIPS, and inflation expectations.</li>
<li>Tariff revenues up sharply; proposals to use tariffs for direct stimulus checks discussed. Risks remain for increased consumption-led inflation and further trade retaliation.</li>
</ul>
</li>
<li>
<p><strong>Interest Rates &amp; Inflation Dynamics:</strong></p>
<ul>
<li>Fed expected to enter coordinated rate-cut cycle through 2025, with consensus for three cuts over the next 12 months; further cuts in 2026 seem possible but not certain.</li>
<li>Inflation remains elevated, with CPI tracking above target (2.5-3.5% YoY likely into late 2025). Upside risks could emerge from new fiscal spending, stimulus checks, and tariffs.</li>
<li>Unemployment remains below cycle highs, but risk of an uptick into the 4.5%-5% range late next year as economic momentum potentially slows and layoffs (esp. in tech) accelerate.</li>
<li>Soft landing remains base case, with low odds of near-term recession, though economic tailwinds may diminish.</li>
</ul>
</li>
<li>
<p><strong>Bond Market &amp; FX:</strong></p>
<ul>
<li>Yield curve is expected to flatten as Fed cuts rates. 10-year Treasury yields expected to remain above 3.5% absent a major growth shock.</li>
<li>USD index is stable with only modest risk of significant depreciation or de-dollarization in 2025; relative strength supported by US economic outperformance but threatened by fiscal deterioration.</li>
</ul>
</li>
</ul>
<hr />
<h2>Sector &amp; Thematic Insights</h2>
<h3>Energy, Commodities &amp; Climate</h3>
<ul>
<li>
<p><strong>Oil/Gas:</strong></p>
<ul>
<li>Near-term volatility driven by Middle Eastern geopolitics (Israel, Iran, Gaza), potential for another ground offensive, and possible US/Venezuela military engagement.</li>
<li>Oil price projections skewed lower: global supply expected to remain robust unless major Middle East escalation occurs; OPEC may be less likely to announce new cuts soon.</li>
<li>Natgas, heating fuels: Likely to see short-term spike from Arctic blast and Asian weather shocks (typhoon impacts).</li>
<li>Climate change: High confidence in continued warming and extreme weather; risk of climate impacting agriculture, insurers, and global commodity pricing structurally by late decade.</li>
</ul>
</li>
<li>
<p><strong>Utilities &amp; Renewables:</strong></p>
<ul>
<li>EU unlikely to meet 2030 climate goals on schedule; India more likely to do so, potentially outperforming in renewables buildout.</li>
<li>Nuclear poised for breakthroughs: expectation for several next-gen companies to achieve operational milestones in next 1-2 years.</li>
</ul>
</li>
<li>
<p><strong>Commodities (Gold, Crypto):</strong></p>
<ul>
<li>Gold expected to outperform inflation and serve as partial hedge against policy/fiscal uncertainty and market tail risk; $4,000+ by late 2025 is plausible.</li>
<li>Crypto markets: Bitcoin &amp; Ethereum remain volatile, with upside capped by tightening regulation but supported by global digital asset adoption and ETF inflows; Ethereum protocol upgrade and stablecoin yields could support sector-wide returns.</li>
</ul>
</li>
</ul>
<h3>Tech, AI &amp; Innovation</h3>
<ul>
<li>
<p><strong>Tech Sector/AI:</strong></p>
<ul>
<li>No sign that antitrust actions will force breakups of major tech giants near-term, though scrutiny will remain high.</li>
<li>AI competition: Google expected to maintain lead in model performance in 2025; OpenAI has smaller but non-negligible chance of disruption. Investment flows toward chips, cloud, and enabling infrastructure (Nvidia, TSMC, hyperscalers).</li>
<li>Satellite, mobile, and cloud launches in US and global markets (Apple, Samsung, SpaceX) continue to increase innovation tempo.</li>
</ul>
</li>
<li>
<p><strong>IPOs &amp; Private Markets:</strong></p>
<ul>
<li>Only a small number of large private companies are likely to go public in the next 12 months; deal environment remains subdued but could thaw if broad indices stay strong.</li>
</ul>
</li>
</ul>
<h3>Consumer &amp; Housing</h3>
<ul>
<li>
<p><strong>Housing/REITs:</strong></p>
<ul>
<li>Urban real estate: Watch for potential boost from new forms of stimulus and any ultra-long mortgage initiatives.</li>
<li>Rent inflation persists in large markets (Northeast/California), with no tax or regulatory changes expected to dampen appetite among institutional buyers.</li>
<li>No major moves on Congress banning stock trading or taxing REITs/PEs.</li>
</ul>
</li>
<li>
<p><strong>Retail &amp; Consumption:</strong></p>
<ul>
<li>Retail expected to benefit from strong labor markets, elevated wage growth, potential for new stimulus, but face margin pressure from higher input costs and changing SNAP/OE policy.</li>
<li>Walmart among those poised to discuss AI, automation, and supply chain competition on earnings calls.</li>
</ul>
</li>
</ul>
<h3>Healthcare &amp; Biotech</h3>
<ul>
<li>
<p><strong>Therapeutics:</strong></p>
<ul>
<li>CRISPR and gene-editing therapies continue to demonstrate disruptive potential, pushing up valuations for select biotech innovators.</li>
<li>Medicare, ACA, and SNAP policy remain volatile; potential for disruptions in insurance provider earnings.</li>
</ul>
</li>
<li>
<p><strong>Pandemic Risk:</strong></p>
<ul>
<li>Measles cases trending higher; ongoing risk of new influenza surge or variant, but pandemic-scale COVID threat viewed as low in coming months.</li>
</ul>
</li>
</ul>
<hr />
<h2>Individual Companies &amp; Tickers to Watch</h2>
<ul>
<li>
<p><strong>Nvidia:</strong></p>
<ul>
<li>Likely retains top global market cap position at year end, driven by AI chip demand, its ecosystem leadership, and supply chain (TSMC) resilience.</li>
<li>Reporting expectations: AI, tariffs, gaming, and automation will be recurrent themes in guidance and forward-looking statements.</li>
</ul>
</li>
<li>
<p><strong>Apple:</strong></p>
<ul>
<li>Continues to innovate (satellite, foldable iPhones), but faces rising competition from Samsung/Android flagship launches.</li>
<li>Leadership turnover risk remains low, but next-generation product launches could shift consumer electronics sentiment mid-decade.</li>
</ul>
</li>
<li>
<p><strong>Tesla:</strong></p>
<ul>
<li>Delivery growth moderate; further upside dependent on execution in semis and energy storage.</li>
<li>FSD/AI ambitions (including potential acquisition of xAI) critical to premium perception, but full regulatory approval unlikely before 2027.</li>
</ul>
</li>
<li>
<p><strong>Meta, Google (Alphabet), Amazon, Microsoft:</strong></p>
<ul>
<li>Remain at the center of tech/AI investment narratives, with minimal risk of forced breakup or top management shakeup mid-term.</li>
<li>Focus remains on AI, cloud expansion, and regulatory strategy.</li>
</ul>
</li>
<li>
<p><strong>Bitcoin/Ethereum:</strong></p>
<ul>
<li>Both assets maintain strong momentum; volatility and correlation to other risk assets likely to persist.</li>
<li>Watch for positive ETF inflows and potential for new sovereign buyers to spur upside.</li>
</ul>
</li>
</ul>
<hr />
<h2>Second &amp; Third Order Effects to Monitor</h2>
<ul>
<li>Sustained fiscal stimulus and rising debt/GDP could sharpen the eventual market reaction and repricing across both risk and safe assets.</li>
<li>Global supply chain risks heightened by weather (typhoon), further constraining just-in-time manufacturing, especially in Asia.</li>
<li>Militarization of data centers (nuclear power builds) signals structural change in utility, industrial, and defense sectors.</li>
<li>AI progress—should any application “pass” the Turing Test—could justify further multiple expansion in the tech sector and trigger broad productivity debates in macroeconomics.</li>
<li>Licensing bottlenecks or export curbs (as in semiconductors, pharma) have potential to disrupt established global players, especially in China, Korea, and Germany.</li>
<li>Real policy proposals for tariff dividend checks or 50-year mortgages would have both short-term stimulative and longer-term risk implications for consumer, housing, and inflationary trends.</li>
</ul>
<hr />
<h2>Takeaways</h2>
<ul>
<li>Short-term outlook is constructive for equities; anticipated government re-opening and Fed easing reduce systemic tail risk.</li>
<li>Downside risks in the medium-term reside with policy uncertainty (fiscal, trade), potential for inflation to remain above target, and pockets of geopolitical volatility.</li>
<li>Sectors with above-average risk/reward: AI/semiconductors, nuclear &amp; clean energy, gold/alternatives, advanced biotech.</li>
<li>Monitor for exogenous shocks (weather, geopolitics) that could quickly reprice commodities, insurance, EM risk, and global supply chains.</li>
</ul>
<hr />
<p><strong>Stay alert for government fiscal signals, macro data (unemployment/inflation), energy demand disruptions, AI innovation, and sector/country-specific shocks.</strong></p>

</main>
</body>
</html>
